Form4insider filings, from the source

SEC Form 4 · accession 0001226488-17-000005

MYRIAD GENETICS INC · MYGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 1, 2017
Accepted (ET)
Sep 5, 2017 · 2:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 1, 2017M10,000$16.46A52,524D
Common StockSep 1, 2017S10,000$30.3056D42,524D
Common StockSep 1, 2017M10,000$16.46A52,524D
Common StockSep 1, 2017S10,000$30.3003D42,524D
Common StockSep 1, 2017M10,000$16.46A52,524D
Common StockSep 1, 2017S10,000$30.2981D42,524D
Common Stockholding———300Iby Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F2$16.46Sep 1, 2017M10,000D—Nov 15, 2017Common Stock10,00020,000D
Non-Qualified Stock Option (right to buy)F2$16.46Sep 1, 2017M10,000D—Nov 15, 2017Common Stock10,00010,000D
Non-Qualified Stock Option (right to buy)F2$16.46Sep 1, 2017M10,000D—Nov 15, 2017Common Stock10,0000D

Explanation of responses